| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 86266 |
CAS:1345034-50-5,DOTA-(COOt-Bu)3 |
129 |
h |
2024-12-13 |
| 86267 |
CAS: 195071-49-9,Amino-PEG4-CH2CO2H(氨基-四聚乙二醇-乙酸) |
148 |
WYQ |
2024-12-13 |
| 86268 |
10-[2-[(3,5-Dicarboxyphenyl)amino]-2-oxoethyl]-DOTA(HCl salt) |
127 |
h |
2024-12-13 |
| 86269 |
CAS: 134978-99-7,Amino-PEG3-CH2CO2H(氨基-三聚乙二醇-乙酸) |
173 |
WYQ |
2024-12-13 |
| 86270 |
2138439-53-7,(S,R,S)-AHPC-C4-NH2 |
149 |
kx |
2024-12-13 |
| 86271 |
FmocNH-PEG3-CH2CH2NH2 中文名称:Fmoc-氨基-三聚乙二醇-乙二胺 |
237 |
WYQ |
2024-12-13 |
| 86272 |
Biotin-PEG2-CH2-aldehyde 中文名称:生物素-二聚乙二醇-亚甲基-醛基 |
172 |
WYQ |
2024-12-13 |
| 86273 |
2172819-74-6,(S,R,S)-AHPC-C4-COOH,VH 032 酰胺-烷基C4-酸 |
131 |
kx |
2024-12-13 |
| 86274 |
CAS: 112247-65-1,Biotin-NH-CH2CH2-S-S-Pyr |
142 |
WYQ |
2024-12-13 |
| 86275 |
CAS: 2100306-55-4,Propargyl-PEG1-CH2CO2tBu(炔丙基-PEG1-乙酸叔丁酯) |
133 |
WYQ |
2024-12-13 |
| 86276 |
Me-Diazirine-C4-Br的主要组成与功能基团 |
187 |
kx |
2024-12-13 |
| 86277 |
CAS: 2098489-63-3,Propargyl-PEG5-CH2CO2tBu(炔丙基-PEG5-乙酸叔丁酯) |
164 |
WYQ |
2024-12-13 |
| 86278 |
CAS: 888010-02-4,Propargyl-PEG4-CH2CO2tBu(炔丙基-PEG4-乙酸叔丁酯) |
153 |
WYQ |
2024-12-13 |
| 86279 |
TCO-PEG3-CH2-aldehyde 中文名称:TCO-三聚乙二醇-亚甲基-醛基 |
206 |
WYQ |
2024-12-13 |
| 86280 |
10,10-[(5-硝基-1,3-苯基)双(亚甲基)]双[1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸],盐酸盐 |
236 |
h |
2024-12-13 |
| 86281 |
2821804-11-7,(S,R,S)-AHPC-C5-azide |
129 |
kx |
2024-12-13 |
| 86282 |
CAS: 16024-60-5,Methyl-PEG-PEG-CH2COOH (PEG1-PEGn) |
158 |
WYQ |
2024-12-13 |
| 86283 |
CAS:1349103-97-4,Ho-Maleimido-DOTA |
154 |
h |
2024-12-13 |
| 86284 |
1393350-27-0,DBCO-C5-NHS ester |
133 |
kx |
2024-12-13 |
| 86285 |
CAS: 157759-50-7,Bromo-PEG1-CH2CO2tBu |
184 |
WYQ |
2024-12-13 |
| 86286 |
Tm-p-SCN-Bn-DOTA双功能螯合剂 |
161 |
h |
2024-12-13 |
| 86287 |
CAS: 1135131-50-8,Bromo-PEG-CH2CO2H (PEG1-PEGn)(溴-聚乙二醇-乙酸) |
172 |
WYQ |
2024-12-13 |
| 86288 |
2193061-18-4,Me-Diazirine-C5-NH2 |
129 |
kx |
2024-12-13 |
| 86289 |
钆特酸,GADOTERIC ACID,CAS: 72573-82-1 |
294 |
h |
2024-12-13 |
| 86290 |
CAS: 100688-48-0,m-PEG3-(CH2)3-alcohol(甲氧基-聚乙二醇三聚体-丙醇) |
149 |
WYQ |
2024-12-13 |
| 86291 |
CAS: 1807512-36-2,Azido-PEG3-(CH2)3OH(叠氮-三聚乙二醇-丙醇) |
144 |
WYQ |
2024-12-13 |
| 86292 |
CAS: 23243-68-7,PEG-(CH2CO2H)2 (PEG1-PEGn |
164 |
WYQ |
2024-12-13 |
| 86293 |
115416-38-1,Biotin-C5-amine,生物素-C5-胺 |
168 |
kx |
2024-12-13 |
| 86294 |
CAS: 1374658-86-2,Biotin-PEG3-(CH2)3-NH2 TFA salt |
226 |
WYQ |
2024-12-13 |
| 86295 |
CAS: 1835759-71-1,Azido-PEG4-(CH2)3-methyl ester |
140 |
WYQ |
2024-12-13 |
| 86296 |
Cl-C6-PEG11-NHCO-C3-NHS |
136 |
kx |
2024-12-13 |
| 86297 |
CAS: 287174-32-7,Hydroxy-PEG1-CH2CO2tBu(羟基-聚乙二醇单甲醚-乙酸叔丁酯) |
192 |
WYQ |
2024-12-13 |
| 86298 |
CAS: 2144777-76-2,Propargyl-PEG4-CH2CO2-NHS(炔丙基-四聚乙二醇-琥珀酰亚胺酯) |
150 |
WYQ |
2024-12-13 |
| 86299 |
Cl-C6-PEG1-NHCO-C3-NHS的组成与结构 |
207 |
kx |
2024-12-13 |
| 86300 |
Cl-C6-PEG6-NHCO-C3-NHS的化学性质 |
244 |
kx |
2024-12-13 |
| 86301 |
CAS: 2128735-25-9,Fmoc-PEG3-CH2CO2-NHS(Fmoc-三聚乙二醇-琥珀酰亚胺酯) |
141 |
WYQ |
2024-12-13 |
| 86302 |
2306389-03-5,(S,R,S)-AHPC-C6-NH2,(S,R,S)-AHPC-C6-氨基 |
133 |
kx |
2024-12-13 |
| 86303 |
NH2-PEG2000-C18 Stearic Acid, 氨基-聚乙二醇-硬脂酸 |
196 |
wyh |
2024-12-13 |
| 86304 |
1,4,7,10-Tetraazacyclododecane-1,4-diacetic acid |
122 |
h |
2024-12-13 |
| 86305 |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid |
147 |
h |
2024-12-13 |
| 86306 |
Cl-C6-PEG11-NH2 hydrochloride的组成与结构 |
218 |
kx |
2024-12-13 |
| 86307 |
1384870-47-6,DBCO-C6-NHS ester,二苯基环辛炔-碳6-琥珀酰亚胺酯 |
117 |
kx |
2024-12-13 |
| 86308 |
DBCO-C18Stearic Acid, 二苯并环辛炔-聚乙二醇-硬脂酸 |
169 |
wyh |
2024-12-13 |
| 86309 |
Cl-C6-PEG12-O-CH2COOH |
128 |
kx |
2024-12-13 |
| 86310 |
2570871-27-9,5-TAMRA-PEG2-C6-Cl,5-罗丹明-二聚乙二醇-C6-氯 |
162 |
kx |
2024-12-13 |